Meeder Asset Management’s MediciNova MNOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-33
Closed 2218
2019
Q2
$0 Sell
33
-552
-94% -$5.82K ﹤0.01% 2097
2019
Q1
$5K Buy
585
+56
+11% +$488 ﹤0.01% 1394
2018
Q4
$4K Buy
+529
New +$5.28K ﹤0.01% 1467
2018
Q3
Sell
-119
Closed -$947 1629
2018
Q2
$947 Sell
119
-906
-88% -$9.37K ﹤0.01% 1507
2018
Q1
$11K Buy
1,025
+98
+11% +$976 ﹤0.01% 1040
2017
Q4
$5K Buy
927
+72
+8% +$478 ﹤0.01% 1313
2017
Q3
$5K Hold
855
﹤0.01% 1267
2017
Q2
$4K Hold
855
﹤0.01% 1261
2017
Q1
$5K Buy
+855
New +$5.15K ﹤0.01% 1078

Other funds holding MNOV

Meeder Asset Management's MNOV Position: Q3 2019 in Review

Meeder Asset Management sold out of MediciNova (MNOV) in Q3 2019, closing a stake of 33 shares.

Meeder Asset Management first reported a position in MNOV in Q1 2017 and held it in 9 quarters. The position peaked at $11K in Q1 2018. 49 funds tracked by Wall St. Rank hold MNOV as of Q3 2019.

  • Meeder Asset Management reported no remaining MediciNova position as of Q3 2019 after selling out during the quarter.
  • Meeder Asset Management sold 33 MediciNova shares in Q3 2019.
  • Meeder Asset Management first reported a position in MediciNova in Q1 2017 and held it in 9 quarters.
  • Meeder Asset Management's MediciNova position peaked at $11K in Q1 2018.
  • 49 funds tracked by Wall St. Rank held MediciNova as of Q3 2019.

Based on Meeder Asset Management's 13F filing for Q3 2019, filed 17 Oct 2019.